Owner SUMITOMO PHARMACEUTICALS COMPANY, LIMITED

Inventors TAIJI, Mutsuo; SUGARU, Eiji; ICHIHARA, Junji

Pub. Number AU-A-2002367266

PCT Number PCT/JP02/13777

PCT Pub. Number WO2003/057874

Priority 2001-401076 28.12.01 JP

Filing date 27 December 2002

Wipo publication date 24 July 2003

C12N 015/00 Mutation or genetic engineering

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61P 013/12 Drugs for disorders of the urinary system

C07D 295/12 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 211/46 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C12N 015/54 Mutation or genetic engineering - Transferases (2)

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine